Clinical and biochemical polymorphism of spinal muscular atrophy
Objective: to conduct clinical laboratory studies of spinal muscular atrophy (SMA) for the clarification of the pathogenetic features and role of neurotrophic factors in the formation of polymorphism of this diseasePatients and methods. Thirty-five patients aged 9 months to 53 years (mean age, 14.5...
Saved in:
| Main Authors: | M. G. Sokolova, S. V. Lobzin, I. V. Litvinenko, M. V. Rezvantsev, L. A. Polyakova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2017-03-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/697 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021-02-01) -
Rehabilitation management for patients with spinal muscular atrophy: a review
by: Wei Song, et al.
Published: (2025-07-01) -
Experience of Nusinersen in children with proximal spinal muscular atrophy 5q in Moscow region
by: M. V. Panteleeva
Published: (2022-12-01) -
Serum creatinine to cystatin C ratio as monitoring biomarker in Chinese adult spinal muscular atrophy: a prospective cohort study
by: Sihui Chen, et al.
Published: (2025-05-01) -
Physical and Respiratory Rehabilitation in Spinal Muscular Atrophy: A Critical Narrative Review
by: Serena Cammarano, et al.
Published: (2025-04-01)